Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

DNA damage induced by the anthracycline cosmomycin D in DNA repair-deWcient cells (2010)

  • Authors:
  • USP affiliated authors: MALDONADO, GABRIEL PADILLA - ICB ; MENCK, CARLOS FREDERICO MARTINS - ICB ; GARRIDO, LEANDRO MAZA - ICB
  • USP Schools: ICB; ICB; ICB
  • DOI: 10.1007/s00280-010-1244-x
  • Subjects: MICROBIOLOGIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00280-010-1244-x (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Cancer Chemotherapy and Pharmacology

    ISSN: 0344-5704

    Citescore - 2017: 2.91

    SJR - 2017: 1.147

    SNIP - 2017: 0.899


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    ICB12100025335PC-ICB BMM SEP 2010
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CARVALHO, Helotonio; GARRIDO, Leandro Maza; FURLAN, Renata Ligia de Araujo; et al. DNA damage induced by the anthracycline cosmomycin D in DNA repair-deWcient cells. Cancer Chemotherapy and Pharmacology, Berlin, v. 65, n. 5, p. 989-994, 2010. DOI: 10.1007/s00280-010-1244-x.
    • APA

      Carvalho, H., Garrido, L. M., Furlan, R. L. de A., Padilla, G., Agnoletto, M., Guecheva, T., et al. (2010). DNA damage induced by the anthracycline cosmomycin D in DNA repair-deWcient cells. Cancer Chemotherapy and Pharmacology, 65( 5), 989-994. doi:10.1007/s00280-010-1244-x
    • NLM

      Carvalho H, Garrido LM, Furlan RL de A, Padilla G, Agnoletto M, Guecheva T, Henriques JAP, Saffi J, Menck CFM. DNA damage induced by the anthracycline cosmomycin D in DNA repair-deWcient cells. Cancer Chemotherapy and Pharmacology. 2010 ; 65( 5): 989-994.
    • Vancouver

      Carvalho H, Garrido LM, Furlan RL de A, Padilla G, Agnoletto M, Guecheva T, Henriques JAP, Saffi J, Menck CFM. DNA damage induced by the anthracycline cosmomycin D in DNA repair-deWcient cells. Cancer Chemotherapy and Pharmacology. 2010 ; 65( 5): 989-994.

    Referências citadas na obra
    Strolh WR, Dickens ML, Rajgarhia VB, Woo AJ, Priestley NB (1997) Anthracyclines. In: Strolh WR (ed) Biotechnology of antibiotics, 2nd edn. Marcel Dekker, New York, pp 577–657
    Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229
    Zucchi R, Danesi R (2003) Cardiac toxicity of antineoplastic anthracyclines. Curr Med Chem Anticancer Agents 3:151–171
    Furlan RL, Watt SJ, Garrido LM, Amarante-Mendes GP, Nur-e-alam M, Rohr J, Braña A, Mendez C, Salas JA, Sheil MM, Beck JL, Padilla G (2004) DNA-binding properties of cosmomycin D, an anthracycline with two trisaccharide chains. J Antibiot (Tokyo) 57:647–654
    Kren V, Rezanka T (2008) Sweet antibiotics—the role of glycosidic residues in antibiotic and antitumor activity and their randomization. FEMS Microbiol Rev 32:858–889
    Case DC Jr, Ervin TJ, Boyd MA, Bove LG, Sonneborn HL, Paul SD (1987) Phase II study of aclarubicin in acute myeloblastic leukemia. Am J Clin Oncol 10:523–526
    Robert J (1993) Epirubicin. Clinical pharmacology and dose–effect relationship. Drugs 45(Suppl 2):20–30
    Kelso C, Rojas JD, Furlan RLA, Padilla G, Beck JL (2009) Characterisation of anthracyclines from a cosmomycin D-producing species of streptomyces by collisionally-activated dissociation and ion mobility mass spectrometry. Eur J Mass Spectrom 15:73–81
    Tornaletti S, Pfeifer GP (1996) UV damage and repair mechanisms in mammalian cells. Bioessays 18:221–228
    Costa RM, Chigancas V, Galhardo RS, Carvalho H, Menck CFM (2003) The eukaryotic nucleotide excision repair pathway. Biochimie 85:1083–1099
    Hanawalt PC (2002) Subpathways of nucleotide excision repair and their regulation. Oncogene 21:8949–8956
    Stary A, Sarasin A (2002) The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie 84:49–60
    Hanawalt PC (2000) DNA repair: the bases for Cockayne syndrome. Nature 405:415–416
    Itin PH, Sarasin A, Pittelkow MR (2001) Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 44:891–920
    Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9:231–241
    Dragovich T, Rudin CM, Thompson CB (1998) Signal transduction pathways that regulate cell survival and cell death. Oncogene 17:3207–3213
    Fedier A, Schwarz VA, Walt H, Carpini RD, Haller U, Fink D (2001) Resistance to topoisomerase poisons due to loss of DNA mismatch repair. Int J Cancer 93:571–576
    Aebi S, Fink D, Gordon R, Kim HK, Zheng H, Fink JL, Howell SB (1997) Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res 3:1763–1767
    Spencer DM, Bilardi RA, Koch TH, Post GC, Nafie JW, Kimura K, Cutts SM, Phillips DR (2008) DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair. Mutat Res 638:110–121
    Robles AI, Wang XW, Harris CC (1999) Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death. Oncogene 18:4681–4688
    Garrido LM, Lombó F, Baig I, Nur-E-Alam M, Furlan RL, Borda CC, Braña A, Méndez C, Salas JA, Rohr J, Padilla G (2006) Insights in the glycosylation steps during biosynthesis of the antitumor anthracycline cosmomycin: characterization of two glycosyltransferase genes. Appl Microbiol Biotechnol 73:122–131
    Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191
    Carvalho H, Ortolan T, Paula T, Leite RA, Weinlich R, Amarante-Mendes GP, Menck CFM (2008) Sustained activation of p53 in confluent nucleotide excision repair-deficient cells resistant to ultraviolet-induced apoptosis. DNA Repair 7:922–931
    Furlan RLA, Garrido LM, Brumatti G, Amarante-Mendes GP, Martins RA, Facciotti MCR, Padilla G (2002) A rapid and sensitive method for the screening of DNA intercalating antibiotics. Biotechnol Lett 24:1807–1813
    Hoy CA, Thompson LH, Mooney CL, Salazar EP (1985) Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res 45:1737–1743
    Bessho T, Mu D, Sancar A (1997) Initiation of DNA interstrand crosslink repair in humans: the nucleotide excision repair system makes dual incisions 5′ to the cross-linked base and removes a 22–28 nucleotide-long damage-free strand. Mol Cell Biol 17:6822–6830
    Despras E, Pfeiffer P, Salles B, Calsou P, Kuhfittig-Kulle S, Angulo JF, Biard DS (2007) Long-term XPC silencing reduces DNA double-strand break repair. Cancer Res 67:2526–2534
    Hande KR (1998) Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34:1514–1521
    Arlett CF, Plowman PN, Rogers PB, Parris CN, Abbaszadeh F, Green MH, McMillan TJ, Bush C, Foray N, Lehmann AR (2006) Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum. Br J Radiol 79:510–517